Baird Medical Investment Holdings LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Baird Medical Investment Holdings Limited reported a significant net loss and revenue decline in the first half of 2025, while facing substantial potential share dilution from selling securityholders and out-of-the-money warrants.
NASDAQ
Baird Medical Investment Holdings Limited filed an F-1/A registration statement for the potential resale of up to 34.4 million ordinary shares by selling securityholders and the issuance of 11.5 million shares upon warrant exercise.
NASDAQ
F-1/A: Baird Medical Files Amendment for Share Issuance and Resale, Potentially Diluting Share Value
Baird Medical is registering the issuance of shares upon warrant exercise and the resale of shares by existing securityholders, which could increase market volatility and dilute share value.
NASDAQ
Baird Medical Investment Holdings Limited has filed a registration statement for the potential resale of up to 33,832,033 ordinary shares and 11,500,000 ordinary shares issuable upon exercise of warrants.